MedTrace Logo

Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.

NCT05094674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2021-10-26

No results posted yet for this study

Summary

The Sponsor has developed a rapid screening tool intended to determine if the subject tested is COVID-19-free (Negative to COVID-19).

Conditions

Interventions

DIAGNOSTIC_TEST

Breath Sample analysis

The participant's breath sample is taken by blowing preferably three times into a disposable tube. Thereafter, the tube is sealed, sterilized, and scanned by the BioSafety Station for analysis. This will take place once during the study.

Sponsors & Collaborators

  • Tera Group

    lead INDUSTRY

Principal Investigators

  • Ilan Lieberman, MD · Tameside and Glossop Integrated Care NHS England

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-22
Primary Completion
2022-06-22
Completion
2022-07-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05094674 on ClinicalTrials.gov